BridgeBio Pharma, Inc. has grown revenue 401% a year over three years and 63% a year over five. Revenue growth, 3-year annual rate: +401% (Biotechnology median +21%). Revenue growth, 5-year rate: +63%, growth has picked up over the last three years. Years of annual history on file: 9, FY2017 to FY2025, as filed.

BBIOBridgeBio Pharma, Inc.

HealthcareUSD

$79.37

$46.5852 weeks$85.86

Is it growing?

Is BBIO growing?

BridgeBio Pharma, Inc. has grown revenue 401% a year over three years and 63% a year over five.

+401%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +63%
Revenue growth, 5-year rate · +401% over three · growth has picked up over the last three years
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›